Noelia Muñoz Fernández

Noelia Muñoz Fernández

Auto-generated profile, based on publicly available information

Noelia Muñoz Fernández

Department of Otorhinolaryngology, Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2020 in American Journal of Rhinology & Allergy
Verified
Journal Article
Closed access
PDF file
Miguel ArmengotMiguel Armengot
Miguel Armengot
MGMaría José Gómez-Gómez
María José Gómez-Gómez
CGCarmen García-Navalón
Carmen García-Navalón
EDEncarna Doménech-Campos
Encarna Doménech-Campos
NMNoelia Muñoz-Fernández
Noelia Muñoz-Fernández
APAlfonso García Piñero
Alfonso García Piñero
Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) is a clinical entity with specific features that impacts significantly on patient quality of life (QoL). CRSwNP is often associated with asthma and is difficult to control and manage despite pharmacological and/or surgical treatment. Omalizumab, a monoclonal anti-IgE antibody, has emerged as a putative therapeutic option. Objective: To evaluate the effects of omalizumab on nasal polyp (NP) size and QoL assessed by Sino-Nasal Outcome Test-22 (SNOT-22) in patients with recalcitrant CRSwNP and mild asthma. Methods: A multicenter retrospective analysis of patient data from the Community of Valencia (Spain) was performed. Adult patients with recalcitrant CRSwNP and comorbid mild asthma receiving compassionate use of omalizumab were included. NP size measured by total nasal endoscopic polyp score (TPS) and QoL evaluated through the SNOT-22 questionnaire were assessed at baseline and monthly over 12 months. An ordinal regression model was built to analyze the results. Results: A total of 23 CRSwNP patients with a mean age (± SD) of 54.78 ± 9.46 years were included. Nineteen suffered from aspirin-exacerbated respiratory disease (AERD). In all patients, a significant and sustained reduction in TPS was observed over time, accompanied by improvements in QoL reflected in lower SNOT-22 scores. In the ordinal regression model, time but not total IgE, age or tissue eosinophilia impacted on NP size and SNOT-22 outcomes. Additionally, improvements in QoL were not explained by reductions in the size of polyps. Conclusion: Omalizumab was effective for the treatment of patients with recalcitrant CRSwNP and mild asthma, even when AERD was present, by reducing NP size and improving QoL; treatment time was a key factor. SNOT-22 improvements were not explained by decreases in TPS, indicating that omalizumab may be effective in all patients, regardless of polyp size.

31 July 2007 in Acta Otorrinolaringológica Española
Verified
Journal Article
Closed access
FCFrancisco Javier García Callejo
Francisco Javier García Callejo
NTNoemí Conill Tobías
Noemí Conill Tobías
NFNoelia Muñoz Fernández
Noelia Muñoz Fernández
CVCarlos de Paula Vernetta
Carlos de Paula Vernetta
ICIgnacio Alonso Castañeir
Ignacio Alonso Castañeir
JAJaime Marco Algarra
Jaime Marco Algarra

3 September 2019 in The Journal of International Advanced Otology
Verified
Journal Article
Open access
NFNoelia Muñoz Fernández
Noelia Muñoz Fernández
CVCarlos de Paula Vernetta
Carlos de Paula Vernetta
LGLaura Cavallé Garrido
Laura Cavallé Garrido
MGMiguel Díaz Gómez
Miguel Díaz Gómez
CPConstantino Morera Pérez
Constantino Morera Pérez
OBJECTIVES: Auditory brainstem potentials can be elicited by electrical stimulation of the round window (RW). In this technique, extracochlear stimulation is objectively used in the selection of cochlear implant (CI) candidates to avoid cochlear damage. However, until now, its use is limited due to the large artifacts generated by electrical stimulation. Our objective was to obtain reliable and reproducible electrically evoked auditory brainstem responses (eEABRs) using a new method of stimulation MATERIALS and METHODS: This was a prospective study including subjects who underwent electrical stimulation on RW during CI surgery between 2013 and 2016. A “Stimulator Box,” which produces electric stimuli identical to those provided by a CI, and an evoked potential recording equipment were used. The results obtained with monopolar and bipolar electrodes were compared. RESULTS: RW eEABR recordings of 49 subjects (mean age, 34 years) were characterized by their stability and by having wave V between 3 and 5.5 ms. A higher percentage of responses were obtained on increasing the phase duration instead of the pulse amplitude. A significantly greater percentage of positive responses were obtained using bipolar stimulation than using monopolar stimulation (p

31 December 2010 in Acta Otorrinolaringologica (English Edition)
Verified
Journal Article
Closed access
FCF. Javier García Callejo
F. Javier García Callejo
NFNoelia Muñoz Fernández
Noelia Muñoz Fernández
MMM. Teresa Achiques Martínez
M. Teresa Achiques Martínez
SMSoledad Frías Moya-Angeler
Soledad Frías Moya-Angeler
MEM. José Montoro Elena
M. José Montoro Elena
JAJ. Marco Algarra
J. Marco Algarra

1 July 2012 in Acta Otorrinolaringologica (English Edition)
Verified
Journal Article
Closed access
NMNoelia Muñoz-Fernández
Noelia Muñoz-Fernández
AMAntonio Morant-Ventura
Antonio Morant-Ventura
MAMaría Teresa Achiques
María Teresa Achiques
DDDelfina Dualde-Beltrán
Delfina Dualde-Beltrán
FGF. Javier Garcia-Callejo
F. Javier Garcia-Callejo
JMJaime Marco-Algarra
Jaime Marco-Algarra

Verified
Journal Article
Open access
PDF file
Miguel ArmengotMiguel Armengot
Miguel Armengot
CDCatalina Bancalari Díaz
Catalina Bancalari Díaz
LCLidón Carretero-Vilarroig
Lidón Carretero-Vilarroig
RBRosana Blanco-Máñez
Rosana Blanco-Máñez
NMNoelia Muñoz-Fernández
Noelia Muñoz-Fernández
TSTeresa Jaijo Sanchis
Teresa Jaijo Sanchis
Background and Objective: Primary ciliary dyskinesia (PCD) is a rare genetic disorder that affects the mucociliary system, leading to progressive lung damage. This deterioration can result in bronchiectasis, atelectasis, and respiratory failure, necessitating lung transplantation in severe cases. This study aims to assess ciliary motility and ultrastructure in the bronchial epithelium of transplanted lungs in patients with PCD to determine whether mucociliary function is preserved post-transplantation. The findings seek to enhance scientific understanding and provide prognostic insights for these patients. Materials and Methods: A prospective observational study was conducted on two patients with PCD and advanced lung disease who underwent bilateral lung transplantation. Nasal and bronchial cilia samples were analyzed using high-speed videomicroscopy and transmission electron microscopy. Follow-up assessments included ciliary function analysis, lung rejection monitoring, and quality-of-life evaluations, with follow-up extending up to 30 months post-transplant. Results: Post-transplant evaluations demonstrated normal ciliary motility and ultrastructure in the transplanted lungs throughout the study period (up to 30 months), indicating the long-term preservation of mucociliary function. Conclusions: Transplanted lungs in patients with PCD maintain normal bronchial ciliary motility and structure in the long term, suggesting a favorable prognosis for both the graft and the recipient. These findings support the feasibility and long-term effectiveness of lung transplantation in patients with PCD.